Kelfred Holdings Limited
1134.HK
HKD0.325 67.53%
Exchange: HKSE | Sector: Healthcare | Industry: Medical Instruments Supplies
Q3 2024
Published: Sep 30, 2024

Earnings Highlights

  • Revenue of $128.08M up 29.3% year-over-year
  • EPS of $-0.01 decreased by 135% from previous year
  • Gross margin of 10.5%
  • Net income of -4.69M
  • "Transcript unavailable for QQ3 2024; no quote provided." - N/A

Kelfred Holdings Limited (1134.HK) QQ3 2024 Results β€” Revenue Growth with Ongoing Losses and Margin Pressure in Healthcare Eyewear

Executive Summary

Kelfred Holdings Limited reported QQ3 2024 revenue of HKD 128.08 million, up 29.0% year over year and 29.8% sequentially, underscoring continued demand for its eyewear product lines and ODM/OEM capabilities. Gross profit reached HKD 13.44 million, yielding a gross margin of 10.49%, while the company posted an operating loss of HKD 3.91 million and a net loss of HKD 4.69 million. The results reflect elevated selling, general and administrative expenses (SG&A) of HKD 20.51 million that outweighed the gross profit improvement and drove EBITDA to negative HKD 2.27 million. Free cash flow was positive at HKD 5.97 million on the back of HKD 7.89 million of operating cash flow, although cash burn from working capital changes contributed to a negative net change in cash of HKD 18.64 million for the quarter. The balance sheet shows total assets of HKD 282.93 million and total stockholders’ equity of HKD 156.43 million, with the firm carrying a net cash position of HKD 15.25 million and a strong liquidity buffer. While revenue momentum appears encouraging, the near-term profitability trajectory remains a key investment risk until operating leverage from scale and margin discipline materialize.

Key Performance Indicators

Revenue

128.08M
QoQ: 29.76% | YoY:29.25%

Gross Profit

13.44M
10.49% margin
QoQ: 51.10% | YoY:13.30%

Operating Income

-3.91M
QoQ: 32.83% | YoY:44.74%

Net Income

-4.69M
QoQ: 23.41% | YoY:-135.67%

EPS

-0.01
QoQ: 22.95% | YoY:-135.00%

Revenue Trend

Margin Analysis

Key Insights

Revenue: HKD 128,084,499; YoY +29.25%, QoQ +29.76%; Gross Profit: HKD 13,438,499; Gross Margin 10.49% (YoY gross profit +13.3%, QoQ +51.1%); EBITDA: HKD -2,268,000; EBITDA Margin -1.77%; Operating Income: HKD -3,909,000; Operating Margin -3.05%; Net Income: HKD -4,691,000; Net Margin -3.66%; EPS: HKD -0.0094; Weighted Avg Shares: 500,000,000; Cash Flow: Operating Cash Flow HKD 7,886,000; Free Cash Flow HKD 5,971,500; Capex HKD 1,914,500; Net Change in Cash: HKD -18,642,000; Cash & Equivalent...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 242.52 -0.01 +89.4% View
Q1 2025 121.26 0.00 +22.9% View
Q4 2024 128.08 -0.01 +29.3% View
Q3 2024 128.08 -0.01 +29.3% View